Tumour markers in breast cancer.

The clinical usefulness of 8 potential tumour markers has been evaluated in 69 patients with Stage I and II breast cancer and 57 patients with Stage III and IV. Serum CEA concentrations were raised in 13% of patients with local and 65% of those with advanced breast cancer. In patients with clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Cove, D. H., Woods, K. L., Smith, S. C., Burnett, D., Leonard, J., Grieve, R. J., Howell, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1979
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010109/
https://www.ncbi.nlm.nih.gov/pubmed/92331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010109/
https://www.ncbi.nlm.nih.gov/pubmed/92331

Ejemplares similares